Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flurbiprofen axetil injection for postoperative pain
CTR20171653Phase 3Active
- Sponsor
- Shanxi Pude Pharmaceutical
- Start
- Jan 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of flurbiprofen axetil in postoperative pain, sponsored by Shanxi Pude Pharmaceutical. Started Jan 2018; status: active.
02
Drugs
flurbiprofen axetil
03
Conditions
postoperative pain
Beyond the preview
Go deeper on CTR20171653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20171653.